<SEC-DOCUMENT>0001193125-13-090522.txt : 20130305
<SEC-HEADER>0001193125-13-090522.hdr.sgml : 20130305
<ACCEPTANCE-DATETIME>20130305060710
ACCESSION NUMBER:		0001193125-13-090522
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20130305
FILED AS OF DATE:		20130305
DATE AS OF CHANGE:		20130305

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Prima BioMed Ltd
		CENTRAL INDEX KEY:			0001506184
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35428
		FILM NUMBER:		13663757

	BUSINESS ADDRESS:	
		STREET 1:		LEVEL 7, 151 MACQUARIE STREET
		CITY:			SYDNEY, NEW SOUTH WALES
		STATE:			C3
		ZIP:			2000
		BUSINESS PHONE:		612 9276 1224

	MAIL ADDRESS:	
		STREET 1:		LEVEL 7, 151 MACQUARIE STREET
		CITY:			SYDNEY, NEW SOUTH WALES
		STATE:			C3
		ZIP:			2000
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d496234d6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 6-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="margin-top:4px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>UNITED STATES </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Washington, D.C. 20549 </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>FORM 6-K
</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>REPORT OF FOREIGN PRIVATE ISSUER </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>PURSUANT TO RULE 13A-16 OR 15D-16 UNDER THE </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>SECURITIES EXCHANGE ACT OF
1934 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Dated March 5, 2013 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Commission File Number 001-35428 </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="6"><B>P<SMALL>RIMA</SMALL> B<SMALL>IO</SMALL>M<SMALL>ED</SMALL> L<SMALL>TD</SMALL> </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(Exact Name as Specified in its Charter) </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A
</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Translation of Registrant&#146;s Name) </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Level 7, 151 Macquarie Street </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Sydney, 2000 New South Wales, Australia
</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Address of principal executive office) </B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Form
20-F&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form 40-F&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b) (1):&nbsp;&nbsp;<FONT
STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Indicate by check mark if the registrant is submitting the Form 6-K in paper as
permitted by Regulation S-T Rule 101(b) (7):&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Indicate by check
mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Yes&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
No&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT> </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If &#147;Yes&#148; is marked, indicate below the file number
assigned to the registrant in connection with Rule 12g3-2(b): Not applicable. </FONT></P> <P STYLE="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SIGNATURES </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dated: March 5, 2013 </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>


<TR>
<TD VALIGN="top" COLSPAN="5"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Prima BioMed Ltd</B></FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">By:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/ Matthew Lehman</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Name:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Matthew Lehman</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Title:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Executive Officer</FONT></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">2 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>EXHIBIT INDEX </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:25pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exhibit</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:75pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Description of Exhibit</B></FONT></P></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Prima BioMed Conference Call to Discuss First Half of Fiscal Year 2013 Results.</FONT></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">3 </FONT></P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d496234dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Exhibit 99.1 </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right">


<IMG SRC="g496234g73z22.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ASX/Media Release (Code: ASX: PRR; NASDAQ: PBMD; ISIN: US74154B2034) </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5&nbsp;March 2013 </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PRIMA BIOMED CONFERENCE CALL TO DISCUSS FIRST HALF OF FISCAL YEAR 2013 RESULTS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2">Prima BioMed Ltd (ASX: PRR; NASDAQ: PBMD; ISIN: US74154B2034) (&#147;Prima&#148;, &#147;the Company&#148;) today announced it will
hold a conference call to discuss its results for the first half of its fiscal year 2013, the period from July&nbsp;1 through December&nbsp;31, 2012. The half year report was previously released on the 28</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> of February 2013 and is available through the Investor Relations
section of the Company&#146;s website at www.primabiomed.com.au. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2">The call is scheduled for Thursday, the 7</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> of March 2013 at 9:00am (Sydney local time). Conference call dial-in
numbers are as follows: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="55%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="80%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Australia Toll Free</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1 800 131 617</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Australia Alternate Toll Free</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1 800 838 758</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">USA&nbsp;&amp; Canada</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1&nbsp;855&nbsp;237&nbsp;2970</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Germany</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0800 189 9369</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The call will also be audio webcast with additional supplemental slides available via
<U>http://services.choruscall.com/links/primabiomed130306.html</U>. Before launching the webcast, it is recommended to click on the link and then on &#147;test your systems configuration.&#148; </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">A replay of the teleconference and webcast will be available through Prima&#146;s website following the live event. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">ENDS </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>About Prima BioMed </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Prima BioMed is a globally active biotechnology company. As a leader in personalized bio-therapeutic products for cancer, Prima is dedicated to leveraging
its current technology and expertise to develop innovative treatment options for patients and maximize value to shareholders. Prima&#146;s lead product is CVac&#153;, an autologous dendritic cell product currently in clinical trials for ovarian
cancer patients who are in remission. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>For further information please contact: </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>USA Investor/Media: </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ms.&nbsp;Jessica Brown, Prima BioMed Ltd. </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">+1 (919)&nbsp;710-9061; jessica.brown@primabiomed.com.au </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Prima BioMed Ltd,</B> Level 7, 151 Macquarie Street, Sydney NSW 2000 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Phone: +61
2 9276 1224 Fax: +61 2 9276 1284 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>www.primabiomed.com.au</U> </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">ABN: 90 009 237 889 </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Australia Investor/Media: </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;James Moses, Mandate Corporate </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">+61 (0)&nbsp;420 991 574; james@mandatecorporate.com.au
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Europe Investor/Media: </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Axel M&uuml;hlhaus, edicto GmbH </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">+49
(0)&nbsp;69 905505-52; amuehlhaus@edicto.de </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Prima BioMed Ltd</B>, Level 7, 151 Macquarie Street, Sydney NSW 2000
</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Phone: +61 2 9276 1224 Fax: +61 2 9276 1284 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><U>www.primabiomed.com.au</U> </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">ABN: 90 009 237 889 </FONT></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g496234g73z22.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g496234g73z22.jpg
M_]C_X0`817AI9@``24DJ``@``````````````/_L`!%$=6-K>0`!``0```!D
M``#_X00_:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP+P`\/WAP86-K970@
M8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/B`\
M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!
M9&]B92!835`@0V]R92`U+C,M8S`Q,2`V-BXQ-#4V-C$L(#(P,3(O,#(O,#8M
M,30Z-38Z,C<@("`@("`@("(^(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO
M+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^(#QR9&8Z
M1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B('AM;&YS.GAM<$U-/2)H='1P.B\O
M;G,N861O8F4N8V]M+WAA<"\Q+C`O;6TO(B!X;6QN<SIS=%)E9CTB:'1T<#HO
M+VYS+F%D;V)E+F-O;2]X87`O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(@>&UL
M;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O(B!X;6QN<SID
M8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B('AM<$U-.D1O
M8W5M96YT240](GAM<"YD:60Z-#!#.3@Q,#,X-30T,3%%,D(T,3)%,C9!,44U
M-C=$1C8B('AM<$U-.DEN<W1A;F-E240](GAM<"YI:60Z-#!#.3@Q,#(X-30T
M,3%%,D(T,3)%,C9!,44U-C=$1C8B('AM<#I#<F5A=&]R5&]O;#TB4%-C<FEP
M=#4N9&QL(%9E<G-I;VX@-2XR+C(B/B`\>&UP34TZ1&5R:79E9$9R;VT@<W12
M968Z:6YS=&%N8V5)1#TB=75I9#ID,V9C,CDW82TQ8SDV+30X,30M8F(Y-"UC
M-F,U-F1E968Y9#DB('-T4F5F.F1O8W5M96YT240](G5U:60Z,V8W8C1A-S4M
M,V0U9BTT,6(S+3AF,3$M,S4R,#%D-#%E,S$V(B\^(#QD8SIC<F5A=&]R/B`\
M<F1F.E-E<3X@/')D9CIL:3YR<C$R,3`R-3PO<F1F.FQI/B`\+W)D9CI397$^
M(#PO9&,Z8W)E871O<CX@/&1C.G1I=&QE/B`\<F1F.D%L=#X@/')D9CIL:2!X
M;6PZ;&%N9STB>"UD969A=6QT(CY-:6-R;W-O9G0@5V]R9"`M(%!R:6UA($)I
M;TUE9"!%>&AI8FET(#DY+C$@8V]N9F5R96YC92!C86QL(&9I;F%L(#`U36%R
M,3,N9&]C/"]R9&8Z;&D^(#PO<F1F.D%L=#X@/"]D8SIT:71L93X@/"]R9&8Z
M1&5S8W)I<'1I;VX^(#PO<F1F.E)$1CX@/"]X.GAM<&UE=&$^(#P_>'!A8VME
M="!E;F0](G(B/S[_[0!(4&AO=&]S:&]P(#,N,``X0DE-!`0```````\<`5H`
M`QLE1QP"```"``(`.$))300E```````0_.$?B<BWR7@O-&(T!UAWZ__N``Y!
M9&]B90!DP`````'_VP"$``$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$"`@("`@("`@("`@,#`P,#`P,#`P,!`0$!`0$!`@$!
M`@("`0("`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`__``!$(`#<!*@,!$0`"$0$#$0'_Q`"S```"`@,!`0$!`0``
M```````'"`8*``4)"P0!`@,!`0$!`0$``@,!```````````!`@,$!@<%"`D*
M$```!P`!`P,#`@,#"`8+```!`@,$!08'"``1"1(3%!46"B$7,2(C03(8820T
M)34F5QE18C,G.!I"0V-$9#96-R@Y.A$``@(!`P($!`0%`@<```````$1`@,A
M,1)!!%%Q!09A(C('@:$3"/"QP4)2,PG1X:(C%#05_]H`#`,!``(1`Q$`/P"U
M?Y4_*)FOC-QRO3CNMO-=Y$[+.DS_`(R<=J^Z!"R:OH;]PQCFGREDTW*\-3(:
M1EFA9!\"2AQ5<H-D"'<N$B]:K5V?P&X?N(6;;+FF1DT?F%I3"\\E[W$)7#;)
MYHHA"97EQ?CJ29<FR6%%P:.K&5YBU5,V^:NLO(S;E):3D72RJQ`1Q>]*5=[-
M5HE+;V26[;_/X';M^W[CN^XIVG:8[Y>ZRWK2E*5=KWO9JM:UK5-VM9M*M4FV
MVDE)R%Y$_DH\9\RN4I4<1R:Y\@FD,\68.KT%B89U2I-=NJ9)9:K.'T+99Z<C
MO400(Y58LDEO[Z0J)B4YOJKU'[K^E]OG>'TSM\O=8DVOU.5<=''^$S:R\+<4
MGNFT?U8^UG^TS]W?=_H.'US[A^M]A[8S9Z*]>T_0OWW=XZV4I=Q6F7M\.&^N
MN.N;+:NU^-TZIC.#?G+XM\U;O&XS8*S8<,U2U&/'UBM7A[%V"H7A\LF8`KT!
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M)%A[_P!2"X)`C['K](HG]7;N7ONE'>>D%2;V.=6.?EO\";?>HBD[OB_)GBVC
M-.&J*5ST2J0$_4X=N[6*@G+68E6G75NBX-,QNZCQ&)=H)%`3'$I`,8-O#9;-
M%XL??RH^;_$?%LVXYR5IR>^;W"<EH.Y6.DSN2V*E%B4H:I)4IRC(B^G91JWE
M65B:7ANLR6:&53.F03=^QB".*8W=M;01)MPCFY2?R_.%+BUQ=?VCB]RXPV*D
MU$P-9IJL4^RMXUJ=0B:DJ]@(VSLK4ZBVGK`RQH]D^6`O]Q(YNQ1V\%ND,<7K
M\#LMSW\JF(<&^$].YVMZ_.<A,=T&>S*,I:F5RT$@K8X?5F#N4K5ICG]C<L&!
MHH[%L4YR&$JX>X`"4#`8`YJK;CJ1*7`UG$'DS7.7W%K$>5-<KTO2*OMV<PND
M1E<L[J.6F*]&3+<[@C.8>1JRT8=PU3((J'2.*?;^WK+4.'N!&O%YYC<(\J-H
MY,U?(:-=:*ZXW6:`BEU[H_KKHF@UJSR5RC(6\5=&"?/%FL,Y5IBHF3=`18@.
M4?T$1'MJU'7<K36Y-N+/E8Q#ECSJYC\#Z'6+5'7KAS\4MAN<HZA%JM?CM9AO
M6+D2IMV+Q>5;_8]L=I1SP7::8*+'[D_EZ.K23>S(=1>L@K2M/R>N'COGV7@R
M3+-.(U4Y$*<;TN0IINC?M:>TEL1Z2E8?B_6`L`55>[D!@5R*7]PP.!#V^NGZ
M=N/(L.)Z%EKKF0SH"J%M_P"5W@F+[_MW'P.%G)N_6/#M1T+,)N5IDC0)%G+.
ML\M<A4Y"?8L$Y524:P[UW'^XF+A,AB%4*!^QA[==EA;4RH:*E*GH.[XTOR$>
M%GDKU,<!J4%J&'[TXBYJ8K^=:[&0)$+JTKB!WE@:TZTU><FXM_.04>BHY<QS
MLK![\9%55)-4B*QD\VQVJIW0=6MP@RWFBRJ)\M,?XDE<4TM;2Y'X'MZ\G+U$
M,]2"0Q-7;4_7%GD0M`^W$)?!-V0_5T/J#^G_`#=3@^'/H(<3T#7Y(/+9PX\7
M%2KLWR2MLT\N5X1?N*!C^=Q;:RZ=;V488B,C-H1+J1B(F!J\>Y5(DK*2KUBS
M%8?:2.JL`I]2M79P@DVX1R]XR_E:>/3<]3KV4ZE2]SXIO;B_8Q]5NNTP58'.
MG"LJN5K$J6&QU:RS#JHL9-TH1,C]XT+$I&-W6=I$`3=;>&_2&7BXDLV+/6;9
MDK(KNFZ+!!JH]6>J*D*U29I)"NHZ.N)O;*W(B43B?OZ0*'?OVZY&3DEXL/,1
MAOE<><C&604.[4!7CQ:JY"/"W=_7'2EVKUN5M:5=NM>2@7[Q1M$/C5%QZDW(
M%53$Z8#_`!ZU:CIN5IK<F7$CRLX=S"YJ<T.$V?UJTQ=UX92;6-G[?+/(-Q6-
M$,WGGM2MKFGHQSQQ)(MZ;;6@,'1G1$_<45(9/N4>CJU56>S((QY'OR+<6\<G
M+&4XD6WC#N6O7*.IE)N2<WG$G2@82*%X:/W;*,81,M)(S;A^S)'G!0"I&`P_
MJ7]`ZU7&[*94%AQ/0AO"_P#)4S'F;RCQSB_"<(>5>92NPV"3K[*^7ME7$ZC6
MU(RKSUG,\G#LUS.BMETH$R!/0'?WE2?V=^K;$ZJ90)1Y%/R-\5\=W+>R<0K3
MQ=W;7KG7:O1K.$YG$G2?I\HE>84TVS81T3*22,XN\8H%$JH`B(")1$O<`[]2
MN-V4[(0XGH"+#?RT_'7H-S8T7;\^Y%\5)!ZY;-E+!J-*B)RGPP.C>A%U97E(
MG9NTP+`3=O4Y6AOC)E[G44(0HF"O#=;:^0AQ)9UJ]IK5WK<#<J;/PUKJ5IB(
MZP5JS5V2:3$#8(*7:)/HN8AI:/6<,9*,D62Y%45T3G353,!BB(#UR(<Y/*OY
M.\^\4N`U#?\`1\NO.LPEPU6'REK7Z#(UV,EV<E,5:W6E*6<+V9ZQ8GCT6]15
M2,4AQ5%18@@'I`PANE'=\45)MP@AW3GI5Z?XYB^1=/,;U8:@IQRJ7(QOD\&>
M,=Z"ZAK=6X2R-:JV4254B'$\U;S94U#$.9$QTS"41#MUGB^7'J0KQ2OYA_'R
M!(BI/\".7%?3<F4(U4GWN>0A'1TBE,J1L>5E6A7!TBG`3@03"4!`1[=PZZ_H
MOQ1I4;V@=#@;^1SF7._E1EO%JN\+N4.52>I%MAV.@Z"UKA*9"DJM*GKJ<\FM
M'N%'`DE&T$9NW$@"!EEB?V=2V)U4MHRQ6K;^7/Q[K.CZ+G#+@]RHMTAFUWM]
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M[M,0W<1R9`_0YW0%']!'KXK[L[/O/4/;?>]EZ?/_`)F3M[*L:-Z:U4:_,IK^
M)][?M>]U^U?8W[A?:'NSWMP7M?L?7.WR9[WCAB7)UIW%YT5>WRVIGL^BQMK5
M'F-NXM9@Z<L7ZA6#YDX79O6#QM(M7C%XU5,@Z9NVJS$BS9TV6(8BB9P`Q#E$
M!`!#K]5:\6OE:T<1JFFMTTU*:V:>J>CU/]>V#O,?=8*=SVJ>7MLE5:EZ6I:E
MZV2=;5LKM6K9---.&G*#CQ>RC2MBY"X[GF-E=/\`1YW0JJ-;5ATY'Y,&XCYE
MG(K6IPX3:E^G1E5;-32#IT8Q2-T&YCB(=NO7V'9]SW_J/;]CV6O>Y,M>$3*X
MV5G?1:*D<G;1+JU)]=?>/WK[1]A_:[U[W1[]=,?M3M_2^X_765TXYJWQ6HNV
MK5V?/)W-K+!CQI-WO=5C4NT?DCY75=.\.'*]:TIM%7N8,,\U>IR3LG8L=:ZK
MHE7:$<I`1-8Q%)6"F7\<)2!W,F^.3^!A`?W#Q2KKQ/\`&O*Y<JJ%.W]`4_B_
M<L+3R7\8-8J5[G%+';N+>@3_`!Z+-.7#QT^D*+!P]?M69_.<OBD765A*?:D(
M8@B'ZH19!$1,(CU<M>-]-C+U>AR0_,W*G\OQQJJND&Q$)/D>J<5@<CW33'#5
M%!(#=NN(B0A!'L/;O_9WZZ=O_=^!NFLI;P+!^0GY9?'UY&N/7'[CWQ,;SVU;
M_`:O5YN+OQ,KMT`^@8)2J3E?E\YJ)YVO,[?:YJ_3TM'IC&,6JC8YV)5#&%4B
M`"QTM1S;1"B<ST0)?/KD-_X\<+/`CD>QN1::+D_'"Y0=Y8O3O'#R)EX2.X]N
M)&N&-\=0QW-93)]/$#"4OK;=BB)?UZN-IWL^D_\`$+5N`X>7;R]<=O-MEN$<
M$."F"WZ\;S;-MI<C4[OKK'/LZ<PLA'Q\JP7J-(D%[9-'%_<32)$GIW#Q@V!F
MB8`(Y6,D4DI1TFUMH*DZ_,]AU_-1Q;LO#+\:GBYQ:O%EC)^Y8UHG&RL6V;8'
M>+0JMF4<728G6,*L=L+MQ"1,I**LV*ATDS*-4$S"0@CZ`S1\LC9FNM_Q'2H_
M(X>)WXK=`V1E)MF-@C>`%>I=)?&760]%ZU)FGF=/=-!!,KD[AA/6Q!T4"D]7
MI0$>W8!ZB4Y8^(:FS2\2M!X%]BG?%;S)OTIMXL8BJ[3XO[/R1A8YVN_:IS-<
M@:0AR(RQ<YW;1H49.6K-7F61"%$QQ7="0GJ,/77(E:OR[\BW:<0?7X!KAKV&
M^5[A]R(V.1*W@?*#7N6$2PE%E9$%[A).;G8G4G(N/F,D$3@YVZ@$1;?SF$Y%
M0$OZF`!9(X-+HT6WS*5T+V?EIYCH\$/'SR2Y%-))M'76$H[BI9.#A84CN=<T
M%9.G9\+<A4U55S1,[+DDEB%*)OB,5C?H!1$//2O*R70PE+A'G]V#Q0R4-^/9
M2_(PD@X3W-;D^XVV5N)0?C.DXUV-VWQFO.5G`-?J"9FNB1C2W)KB3M[<BHOZ
M@#L8?3S3R</[8-2N6OT['H(>*/F*UYX<`.-W(]5^U?6^R45K6M43;*^X++6Z
M&JI3]%26(*:2C8']DAUGR!#E`WQ':)OX&`1\UUQLT9>YT0ZR0\S_`(J>1*B^
M,?S@>3S=[WF.E;+%W#2N6&7M:KD3%L^LD=)2?)>/M2<Q)I2YF+-.%01JQVZA
MR*'.59=/L40[]>JU>6.JT6B"UT&]\81H/RW>?68\D=;6QGC'3\G>*6]/CJ.B
MPBW(709NOY2\S%";5H;*.AWTBG).9<TC:)@J`-6_M)LO4Y54,YZS?Y,?#=LU
M,5@*5R1)_P"<YK*OR4/5_NW_`)OV<>__`.`AX']C<4/X?K_?_A_E_3J+_0?G
M_4J^AFUPG+ZWY'?RJ.6\UR"8Q&@T+A9!V$]&SJR-U96NIJXTM0,RH;5S#/FX
MQCJ-B[Q=92SBW-ZT5)8Q%3E.'<!K^7"HZDF*^9V._)6XA9+R"\6N\Z78:M`$
MT[C)7F.L9?>#1K4DW!M82:BFMRJH2:+8[\U7M=/>/&[A@`BW.Y*W6$@J()F+
MSQ-JZ^)$VG*$TR?R`6NH_BE+<A[7:C.]-@N.=[XOUNSR3MT9])VG]PIWC3GT
MH1RHB#YS)Q<$NR=G4$IE#G9**"(_J/6G5?K1TD0YCJ<"?!#ML_XHN5F\J;:+
M"%A=1\7,IR=KL.\7D&R,PR@*%#\B,?\`6#MFU!21FJBK+,2IE]1_DN#)D]0]
M;NN==/$U=IQ!L?QY+/K/'_RJ\3]?V"42;POD^RWD\C%R2RLA\BWO27JTRCF7
M=_+9MT3JR6OY(N1OW.83I.R'+W%0`&Y(=&ET8MJM-D'KS/<A*WQ(_)>R+D_;
MH::ME;Q&G\=+O-5&IID5MLZQ:U.]QQV4$F^^-%G?'/)%,4%G"1!*0W<P#VZS
M1.V.%N%K1^98L\>?Y$W'[R)\HJMQ9S_CGR"SFSVJKW6TM;7H+:HIUAJVI$/]
M9>M'1HB;?/ODOD?Y$?2F)?7_`!$`ZYVQNJEP9:^*.*O+M$@_F'<9%?DMRF!S
M@W]`P./>'_N!OH?IZ6YD/Y@_AW.'76O_`*[\S2^A^:+"7G=\?N&<S>`?(>U6
M^H5EGM&#9'?-CQ_7?IC5O;JM,9K7)&XNJ\K/MT2R3NG6Z-AUH^0CUCJ-3%7*
MN5,'"""A.6.SK9>!E-K5"`?B);I;=*\=&AY399EQ.Q7'OD!/57/UG"SQ<(6C
M7>J5C0F]6:B[22%)A$6><E54$BAZ$4W0)E[%*4H7,DK3XFKJ'*ZFE_,/3*KX
MW\3*9=%N`<PZ2/K6!82"/[1;2'I#V$5S^H>__1V_3^/5P?7^`Q_4=XO&$`%\
M;_`HH&*<`X>\<@`Y/5Z3`&2U,/47UE(?TC_9W`!_R=<[_6_,R]RKI^:4D57*
M>`@&<(-P#0>0@@*X.!`P_9>?!_+[#=<>X?Y>W77!NPNI<NR#_P"TV7_KW_[N
MZ3^OZ_K_`+M1GZ_J`#^O7`A2#_%K2*GY2O+`8KENL)DKAW(E\CUD_P#R@O8_
MS^\W1)^G?M_*(_KUZ,OTK^.ATOT\@N_EO<`L+A\/S+GQGM9KN:[0RV*N91IL
MY6(\M?4TR!N</8Y.N3U@"%;D![>*38JVD+.4,3YHLW2J:BIRH-@2SBLU->D&
M:I.T/8!7_.NY:_\`$!]__/)^Y_\`IDI_XEO^/7^C_P#S-_[7^]_U.M?IU_ZB
M\'^<'*/FO9M/\0WY"FB<@%H&1?MZOR7>\DJY')J>P&D81O`RCZTQ$6^4*5NJ
MY=5ZS3L%[@_TT99@;U]O0(=:K\^./@:4VI'4]-#C[O\`DG*7&\_WW#+E%WW+
M=,K[2Q5:QQ2Q%"*MG)1*YCI%N!C+14]"O2*-)!BN!'+)XBH@J4JA#`'F::</
M<Y;"W[_XP^"/)VSN[QL?'2G3MVD5/>E;?!.K!1;%-+_P%Q/R=%F*XO/NQ*`%
M]Y[[ZWI``]78`Z^,^I>S_;?J_</N^^[3';NGO=<J6?FZ.K?XR?LE]LOW>_N/
M^T'I%/;WL/W5W_;>W\2C'VV:N#O,&)?XX<?>8LZPUG7CBX5EMQJPH<<N%'%;
MB4V?H\><2IF;.Y5`C26GHYLZE;9*M"'*J5E)7"PNY>T/&!5B@<&YW8H`</4!
M`']>O9Z3[>]$]#5O_E=MBPVM]5DIL_.SFS\FX/AWW5_<!]Y?O;EQ9/NC[A]0
M]6P8+.V/#DM7'VV.S4.].UP5Q=O6\:<UB5VM':"K=^61Y+Z+5,-9^-G,K*RF
M]7U>8J=RY!-XEZDY+G>5UB3:6VKU2P"@)P:6?1;1',':3,YBK)0S%154@)NV
MIE/S^*C;Y=$?4-%+GH.-^*%QJM6'^,E?3;BP<Q3WE-L=HV2L,'13)*_MRPA:
M]GM-E3-S@!TB64M0=2;<P@'O,7;=0.Y3@/4S.;_@2WU,YD?F@+-TWOC=(X51
M3*K*\CR"590A`4(8^%E4+V.(`8HE-V$/^@>M]O\`W"O7R+;V!\#N$V".(.[X
MIQ*XYY9="Q;%1*X47'*#7+2@9=BD5<S6Q1L$A,-??*<?7[:Q0/W'U=^_7!MO
M=F2HG^9:LW3T'QI%7513!1??B^E8Z92J%&?P4#%]*@@!RB!NPA^H"`]=L'4U
M7K&\!._*UX"U*I8'Q_\`(+Q\H]9S&[X5>JY3-1GL]KL;5G1ZW:G3%YEU]E#0
M+-B@I(9WJ$6T:M7:O]9,)P"^KT)E`LPWA\7JF*ZVAF>:/F=`<]?QKN/'*9D]
MC@E]`V3CVTT1DT<-A2@=7JKBWU?2X0R:)O2U(VN$0[.W3-V,+-1$_;TG`147
M'(T*_5^(E?/C0Y?2_";^/]XYJ`_35O/,]UC:CF+9K@9\I7ZL$;2X(RJ!#>M1
MDO>=/9NR_H(":(.;_P!#JTTM:_1)C=LF7Y6G"!U2M2\:DYAD(L4UXS!#@96(
MN,3.BN]EZ3(0+;':\X,V]`N!F8F\R3,$Q$0.@U,40$@"'5Q64.=]RUM$C%^>
M+CU#^,[`/!5M&;H-VC+Q[;31<NE9]J44/JJ:453]%EI)RH?T]E+5-Y',N5?5
MV]Q634[_`-X0ZS2W)V3ZHSXD<_)XW^=YG\JN`/B=X]S[.<E=%LM)U2U(L78N
M&"EJV!RK3<>5FFZ)B"+"HT-U.61T`CV*P?(+=R]@$+BBJ=V6NGS!B>?C'>0!
MYEBF&N/-CKCS%!J:5#+D#NGZF;,3TEHW3:LJ>I13<@U:V6L(-T$TRL0;F;ID
M(`%)_*'19:ISQ4A6AS"D"_XI'(JT<>>2O-;Q.[4\"%MU;N%LT2F5Q\[]`L=*
MRR82S+<J_%M5/YSFFHAA#3"!0`/6V8.5NP]Q'IF4I70:6Z+TW7`R>;1P2\B7
M&+QN>=_RC[5RBLMB@:+:;YRUS.(<5&J2=VDU+9(<HH:RMFKF*A04=-6AHNLN
MA%<X>V50I2B("8.O3:MK8ZJO@C2JVM/$F5?Y`U_RV?D@<6.2?CIR2]4ZA9G8
M\EFMAT92M-JL^EZIG;^POM3TS2&\([>QM=:W.ERQ*BS0D77SYHA6Z2B8&4!%
M-'#$U8L<:Z[C47-=#_SHE91]Y+WO]VOZ7N$]W_P"O#?]GZO7_=_7^'\.L+_0
M_$+Z&?URAODKX-?R*;-S6U>K6ISPUYV5Z:0G+S7XES*$CCW*,IY]`:-TFQ#E
MD+/G>HTAG-N(H@B^=5Z2%1LFHK_(&E_W,?'^Y!+E6.J#CYUO.UP^Y*\*[!PG
MX%7]_P`G]JY;2=3SI=KGM*O!$:Y4W-EB):2B4BV"OP;V:OMW6CT8:/B&2#EP
M0KQ=9Q['M)E5E,=JOE;1(E:SOHD)UY.^/UYX_>-WPA^#M%TT3W+D=L4-;=A@
MXMR1=PRL=BMAPD(\YT3G*\80>@[JZ*19/NDM]MBJ41`H&Z5M-K9/@-&VS]_*
MNX/2$#R+\<DMA$`=LILV8,>#=6B8H#IJ.[%0[%`QN60;H&XD%<DE`Z4LT]`A
MZ%&T>8!*)2#U<5E#3+6T#-^>+#:WXS*=X%]WS9LW8P/`K7Z;B\K-H$*V3DX2
M)8T*[NG;T5/2'O68,RL+A<##_55D5>X?S#UG&^7*KZHRM9$T\MW)').-7Y/7
M'WDOJDZNUR3+JEQHT"TR\''.+#(!6!I5\21?Q4-'@H]EC*'DT#D(B4QQ(;U`
M'Z=:JN6*%N:JIJTMY++G%[\B;Q:<M-_S#C?A]STA_K&N3CJMTEE+XK::U&.9
M)K"2D^X2>3CULFTCT?IL,N;U'$`$Q0+_`!$.N3Q6JI>Q'5K5E:3RI\C<KXE_
ME.YER,VB7?0^99##8#:;J]AXMU/S#2(4Q:UPQ%6,%'@>0DEOG2R`"FD43>@1
M-V[`/7:FN%U6Y:J:M+>1C/*Q^25G?-S![7P6\8F8[=JF@\D8Q7-K?>5Z!*L)
MEM2K$)65BJ.99[%*RUVL=IN4:JI&K/'31DSCF3A8Y/?5,0R,IB=7RO"2)$/Y
MMCO3^/IX[;YXYN`,/1=E8-H?=-DO,SMVJ5QNNV>#2'L_$05?JU`<OV2[AB]D
MJQ4:XS^>=`QD22;ARFF=1,A%#<\EE:TK8RSGM^8N=,GC=Q#W%$T@/S'HY"F5
M.5,HF-D6U=@]1Q`._6L&E_P-X_J(_P`*?R;_`!/X'PTXLXQH>D:TUO&0<=<?
MSJZMHO$[G+1S6STC/X&OSZ#"4:(&:231&2C52I+I"*:I``Q1[#TMCNV[=`Z6
M$^_,+T:JZCQC\8>IU1ZHI4-,>Z[?ZHZD4#1CMU7+CEV76*$7<L70E69NE8R2
M2,HB?^=,PB4?U#JX/J9E=2[;CX]\DRT0_4!SJD"`A_;_`+LQG7`AYOWAG\F?
M$_QG>1+R2Z)RJM%G@:[I5ET:F5,U.ITM>7SJ>A>1-WG7S=XRA"J*QR)8]8IB
M*K>E,YNY>_</U]-ZN]5Q_C0ZVJ[1'@%WR<^1;<_R,=;Q[A!XX<%TM[AM.O*%
MRE;7;8HK$9VXK,75<8Z+J;J)<R]:RS+L[A9I^HW3>OSR,BNZ,;V@7*V:C*T6
M-<K/YB)*FKW+*O\`Y?G#O_K)7_\`4Q_RT/\`9A_]N_\`''_2/]H?_!?P_P"O
MUS_4M^<F)?YR$7SB>'*G>4[$8Z:J1XVK<LL5BIMQB5Q>KDC8>U,7_MO9/(]`
MD$FCIR6I6)XV*HR=E*8\-)B#D@&14=HKRE^/D*V=7**'7`/R@<V/!]O^@Y2_
MS^=+68^XC%\@^(NLRLC&,4K"S.V1?62I.2-%PI-]=0Z1?B33(KJ*F69D%'"3
MU`&RB?>U:W7Q\3JTKJ5N>D+P"\HG$#R/9(MJ/'_2&"<E7(M-_J65W)RPK^G9
M"L"0G<DO->5>*%1A2&3/[$TT4<PSPA1%%R8Q5"D\]JNNYQVT*[?F`_*0I.1J
MV?CGXW'U>U72DPDH"Z\G5/:ELPSYT**[)PUR)(2+1^G7*/<CZ@E5"JUMFHF'
MH"3$QB(]*XM)OHC=:\O(X0>%_P`.6J^7?<9GD;R1_<!'BI'760L6O;!9['*/
M+IR0T(S\7TS0ZE/RC4S^;,_?"(6>>*<R<>W,9H@<'IR_&W:_!0MS5K1\M3T^
M*W7(&G5V`J-5AXZO5>K0L77*W`1#5%C$P<#!L4(R'AXMBW*1!G'1D>U3102(
M`$32(4H```'7F.1`M.P;#=L&$-LV,91K9JR9Z>N&T[.JA?1KYY+XGU$\(-JA
MY48HS_X"'OBA[8J^RGZN_H+V3`"J0A$R$33(5--,I2$(0H%(0A0`I2$*4`*4
MI2AV``_0`Z`%&F8)A>U+0;G8\7R;6G%8%X-:7TS.:??%J\,@=FH_&#5M,/*G
MB1?*1[<RWQQ3]TR"8F[B0O8"87*C4K1:M*T?0:?5KW2IU!%K-T^Y5^)L]6F6
MS9R@\;MI6OS;1]$R*"#QJDJ0BR)RE43*8``Q0$`!@'%GC&7/3Y&7CGA`90I/
MA;#Y@&0Y\&>'M(`4H68U*^WOMLU@`I`#YGQOD=@#^?\`3JR]^H/M)QKXZ)2.
M=2Z6!8JE+9`R;1N2RB>644DCEL<S<&=LV&<O2P0.:0R:.C"JDE&&:IIJ")B@
M!OUZ2P3JUYWG]\<59W>:-3KH[HUD97*E.K9686Q.:?;XTBJ<=:ZNO,,GBE?L
MC`BYRHOF@HND@.8"G#N/4!\&DY/EFRUXE1U_-*!JU33D6\NG6-)IM=O-=)+,
MTG+=I*$A+/'2D:61:H/%B)K@E[I"*G`I@`Q@$"+-^-W'=I?HW5VN"XPVU*&;
MQ[.'TM#+J.EH$2TB($E5B6L9<DX(MB8-XNL)%C6Q$G)"H,"@W(`)`!.K+B.@
M#3U`!N/XZ<?8G2G&SQ6%8Y&;"[=OW[O5X_,:2RTIT^E6!XJ4>.+TVA$K0NZD
MHM0S9PH9T)UD#"F<1((ATE[=`&3H!8YSA/PTL\U+V2R\2.,=AL5@DWTU/3\Y
M@N5RTU-S,FY4>24M+RC^J.'TE)R#M8ZJZZRAU55#"8QA,(CU4VMFP%[/<IR[
M(XA2O93FU!S&`66!RM!Y[3Z]2XA5P!1("ZD;6XZ-9'6`@]@,)!-V_3OU-]P:
M-7`L*7TXFV+8MDJVS)>CVM<5SBG*:>E[<0-?3]N_&AAM1/;@#"Q+V=_HS'V0
M_I_R]67MT!]6P8ECW(*C2>9;GF%#U[/9@R:DE3-&JT-;ZZZ70*H5N\&+G&;U
MJD_:^Z847!"E71,/<ARC^O1-K5`63CSXQO'SQ/MY]!X[<0,*RJ^"1=-"ZUVC
M1BELCDG)#IN486Q2A9"7@D'*1Q(H1FL@0Y!$I@$OZ=':SW;$L:"R8OCMQO%6
MTZW91FMITFC$*G2="L=%J\Y>*<F1==T0E5MDG%.IZO%(Z=*J`#1PB`**&-_$
MPB*7MT!NK3G>?WE]4Y.[46G7&2H5A;VZBR%IK$)8'U+MC1)1!K9ZF[EF+MQ7
M+"V15.1-ZS,BY(4P@!P`1Z@-=I61Y3L\`A5-AS'/=8J[:20F&];TJEUN]0"$
MNV;NFC>51A[1&RD<E)-VKY=(BY4P5(FL<H&`#F`0![<^)'%/1YA*Q:'QDX^7
MVP(149`H3MTQC.+3,HP<*@+6&ADI2<K;YZG$Q#8?;:MP."+=/^4A2A^G53:T
M38/FJ'#SB/GUEB+I0N+7'*D7&ON3O(&V5#$<SK5EA':C=9HHZB)V&K#*4C7*
MC1RHD)T52&%-0Q1'L80%RL]&W`EFPOW%'BYJUF<W34N-F!:5<7K9FR>6V_X[
MG=QLSMG')>Q'M',]8J[(RB[5@A_(BF=42)$_0H`'16:V;$LE.=85B./@X#),
M<RO+0=$]MT&=9[4:2#E/N`^VX^V8B,]XG<._8W<.I+>X"IT`.]*R')]FA6E:
MV#,,\U>N,)-*:8U_2J56[U",YE!NY9H2S2*M$9*,6\F@T>K)$7(F54J:QR@;
MTG,`U-K8`2'@5P8,`E-POXG&*8!`Q1XZ8^("`AV$!`:=V$!#J\K>+++";>N.
MG'W4(*JU?3,*QO1*S1&OPJ/7;UF-)MT%367PFD9\.J1$_!R$?76OTY@@W]MH
MFB3V$4T^WH(4`S+(%ULV;LF[=FS;H-&C1!)LU:MDDT&[9N@F5)!NW02*5)%!
M%(H%(0H`4I0``#MT`L3W@WPHD7[V5D.'W%M_*2+YU)R$D]X_9,Z?OY)\Y4>/
M9!Z\7J1W#I\\=K'555.8RBBAA,81,(CU>5O%@/%,H-%SF'3KN>TNIT2OI'%1
M*"IE<AZO#IG$``3IQD(S8LB'$`[=P(`]NH"6=`9T!Q?\NGAAXL^3[/'EDNRK
M+&>1-&KKT*%R6AF;)-]$1K!)9Z%<U-FLJR:WG,TS`=11!TNBZC.YUF+IL)E@
M6W2[KMMX%5FMCS:>07(^F950)WA1PMLZR&#D<),.0O(.'07KM[YV7Z(5.1[-
MSSXIRS<#Q=KDD"J='H_O`T<-2A,2Y',B[`&OHC6;;^'A_P`SJJMOE;<Z4?CS
M^('C]Y.M.T*W<@=>8EH7'N2K+FP\9*LY?P^BZ:RG$EEX>:GK$4&PP61KO6*S
M!T:'.K*.7*)VYEHXIT57&<EW5:;OJ+V:T1Z;]!H%(RNE5C.,UJ=?HE!I4*QK
MM2IU4BF<'7:Y!QJ)6[&+B(J/20:,F;=(O8"D*'<>XCW$1'KS3.K.)+^@!AKF
MU9+@E40O6TZ)4LPISJR5FG-[)=)EI!0ZUHN<RUK]6@DWKU1-(TE.3+U)NW3`
M>YSF_L`!$`"?T!G0&H1L$"XG'U8;S<0O98N,CIJ3KR,DS4G(Z'F',DSB)9]$
MD6%^TC)5W#/$FRZB94EU&JQ2&,*1P*!M^@(%9]1SNEV>FTNUW&!@+7H:5K6H
M]?DWR;:4M*5%A/N2X'A6IOZCTM<@?\[=^G_LD/YA_3H#84*^4W4J35-'SRQQ
M=OHEY@(NTU"TPC@'<18:[--$G\3,1CD``%V3]FL11,_8/44P#T!+>@-;,3$1
M78B5L%@E8V"@8*-?3$W-S#YK&1$/$1C55[)2LK)/54&<?&Q[-`ZRZZQR)))$
M,8Q@*`CT`M''[G!Q+Y43D_6>/F\T'4;%6HAK9).#K\@X3E5*H_>&CF%SAV,F
MUCW%DH[Z0+[",W'%=12JPE(1P)C%`:TUN(&IZ@,Z`SH#.@!YJ^LYQAN?V+5-
M;M\10L\J2+-Q9+;/*J(1,.C(23.'9*/%4DEE"%<R<@@B7L4?YU`Z;Z``&#^0
M'A?R?N3G/N/G(_,];N;.*E9MW7J7,*2CYM&03UE'33E<"MB(I?2G\B@BX(8X
M*)*J`4Q0'N`:=;+5H#A=9!G0&G9V&`D)B9KS"<AWL_74HQ>P0;239.9B"1FT
MW*T*M,QB*YWL8E+HLECM3+D(#@J1Q3]0%-V`W'0&=`9T!IS6&`)/HU0\Y$$M
M#F'<V%O6S23(L^O`,GK2->3B,.*P2"L0TD7Z""KDJ8HIK+ID,8#'*`@";>>2
MN#\8:O&7'?-0J^904[-MZU73S[I8\I:;(Z06=(5ZI5V-0?V*USIV;95?X<<U
M=."H)'5$@)D,8*DWL"2Y!LN5;_G\%JN*W^KZ9G=D!X$-;:C*-Y:)=+QSQ>-E
M&"BJ)O<92L1)M56KQFN5)TS=)'163(H0Q0FVX"9T!G0&=`9T!G0&=`9T!G0'
M&;\@W3K]DGA^YI6C-W,A'S\E1JO07TO%J*(O(>HZ;HU.SV[ODUDOYT04J5E>
M-Q.`AZ`7]7<.W6\:FZ3+52X*_/X\/@FX_P"\\.K%RVYITI+3/\3=;M](Q*CR
M#E5JRSG*DWSRLO-2BEFJB;EAJ-HFHM=6&D2>E6&C6Z"K<05=JB7IEN^7%=&:
MM9S"Z"9^-#CMM?BN_)8J7#5G89BWUBPM-,J/ULP?'_<7CK<LIL6I46TS[)H(
M-$Y:ORM/CS/RE_HHRT6X*GV3,`#JS5\3L&U92_J/1KZ\Q@SH#A5Y4:M9^6FO
MTCAG6<4ON\4^I8#LFT:W"9_9\FK#VG7?7ZG<>/7%^U/7NM7W/X=1>OOGM[GV
M1&SE=ZWDX)DY*CV3`W72CX_-U_B0:;@MS=ONNZWQ6E]FOKRCL7'C+VIWN]&L
MT\QC*S&\H^+?(_/L<Y%3TBFLL5B6<H4O%RP.E@5,#6*>E5,/LJ%4%:L)^?Y/
M8?R$<H&J\L]]P#B]I<1M6G;W&H\"$]:ON:8YS=8\4N3]+FI[6]5"/Y:NDK+$
M-:-N]4F*E5$H>,B[7*M(",?0:_R6KDK\XI-$VOCX`.V=3\)>=SYA<RLUV7D.
MX?7#PR<8^2.=N+??I:LNGXWRH<P#,)Z?S&)70I\4X@74&VDVD>P;?1H*?>O'
M$>0@.NYC^F(6X)+#N-/5H/CUQT^V<KN0&^\K,.LW+O3FDARQD.+V>3K2&S'$
M&-LE);7*=6YW2Z!0Z!,7]D6O43/V94I%P_<2<X*WQU72KJ]%"'4&_&#;;WL$
MIXL[A<=`4T&?K>I>8?.H:_!=3Z*[GJMD;32:/07JFE+0-6<Z.O&U6O,FY+$M
M&LG,T1N5ZLD"RYQ$TE,?`H-8'D'K^X\:Z;-DUW>96Y85XI.,^\;=I,QS4D^(
M.99O=-;S>Z7*$UQ-7.L^NM\Y`Z?;1JRJT@C9&RE)8$8(-$BF=/'R?2$G'2?`
M;!6IUUY`<JJER0TNX\J^05%7RKQ2<$N3U*@,=O:^8P\=R%U+`]TT.T:3)-*^
M@E];CGDU2F8J5I][]:>%]?S&+GTH^R<+HMV0;WR(VBX[!X5RZ384G,JUN&6\
M0M:Y%M*XP6]<MAZ^@8M?N42+6,CBF/\`0ULC+8#O6R8"4\45=+L)3>D97ZX\
MP2SG9R7X/9E&UW6%;-+J[90>%_)O7\&U'C8U@+G<,NX_+U*F1=KO<4@I(GS`
MM3M$L^KC:L*6IL[K+F=1;J$``:K*I1*STZ2/@((ZV#DE@%XY29@\O=[HTFIX
M;^47*!.E67FY<.8][IFGYLYJ\9FVMN+%;:)6$<AL\DWM4F"C*MOW];E%F1%V
MQ$OA$46U"<><!A+N^C<CN(-;KV@9_NNU[MHNN^(WEWR8L5>V"UN-`K,ER+P.
MK\>K/1+YGU#<H!#Y\A[VKRK9W7J^DSB9)DFV34;*.TP<GFCW4:EW-+R,U2R\
M1N+MON/'#G[J.PZ-IG%/CYHL[&ZU?%--)6JAJ'(#*<UMW.NJ:19(ZU5O$J\V
MIN@30A$M(T]42,U2E6D4"$(^27)2X8\R*;?H'+_COD_-JOUC?6M`4@\-XL76
MCU:1Y@6[F3NV1Z)>.1\/0_W73M-\S>HS$1E&PT\RI!A)&0>M'#^)=&8(-FKI
M<HWY;-+J0L88[F*>/9[!4`EZTK2E(<TDX=WC7+B_O5^L,A+R;R8D'LU8'Y4@
M]L7KXY6K-JBV81[4J;5H@@V222)S!7DB;1J,?Q;"L95KUQQB:UO\@+D!B]AO
M=$<L4;*UH5_YF[3#7*,C32;20C0>O(8#E:F7073;/2HKBFI[7H-U:U\J_P!`
MS5;;:>41=:Y^Y]4]LLN=5C@3F>+P.'Z!I_/&X8ZWS2O/,(@M#0Y1;W`R&8Z5
M_BAC+II+B1CI=Y<';^.<M8%U&-F:+WY3E:)5A-]1H1[FWR5W,:+SMY`TK2-(
MKUEX:4S)H>?OA>8LQA.%9GR#2Q#-=26IF'\;:QFMB4Y*UB\R]Z9+++Z:5F-@
M4EQBHTZ+=L"J=JJRO!E6K@)^@Q\WEVI^>7D'1=7U^NZ=4.#V::94BCJ5J>U^
MM6*U\=-KM$=/1M4?R*\85&DV&N>FMB<ATX4I7"+02%.J7J+5)?$+70)JF0:7
M+<HYWCP_YE\QBY]</'Q$<J[*I&;E/0UP_P`0#*]RU#;W"H6^.*C-YU3%64D+
MQS38-1E4G;]HS%1@*"2S=S)TF%N29%NIO(7ESRQGN-=/L%UGDX;_`)2O&;E2
M\=5;EO)<*I2\:IJA+5&['NKVRTG-K@YO<=E"E6BO7"+F;5>'<3(N)!D[3>M"
M-]0JSY^`#ECZW('EKL.3YOL?,&^$@_\`E.XOM]GG.&^M3="H^H;-8=>UFJ16
M[5:]0,%4K$I'2U=A4'XM6K:/AI98Z)7+19DW2;&S*2T74&AX4$G>0',SQZ\C
M].U+5'^F:)X?F&L6E.,T:?K]-MMP8:)@L#/'6HD4Z:UDU?L2TZ,I+Q+=N2-<
M2PMW1D2J))"%:A-+9,#H;"_AZUYF>(TWK+UDPIEFX4<CJ'QL>V!=-&$2Y)+:
M?E4_I$-`+.CE:-M$LN&1P"S(`@[=Q$=)D1]1"+AU%]#\9`M5HTG#=.Y8Y9@7
M&B_7O&<!Y%<NN7X\JM-QZZVC-/WWY=8CBV1/B9GFNIQ,V1Y"LK$5Q).+&O4%
MXIQ,3M%D6@K&6)*BN6TO=%Z?$%N/:;M^TZ1QJXXR?)O;I+%B<W_(]Q\8ZU5+
M^M`Z-R'P+C_F03=%2L&L5E)A+2DQ2=`!]7%[5#JLY=[]NJJ@[*[<+N36$DWU
MA$/HR"Q[O3Z[P]W"4Y5\A;_9W'E&T_@G*05TOZDCG]MXXU#7^2&)P,+>*(BU
M;UJVZ:A&9U&2SBZ.4!M#F71$QW?QS&;#(7Y2"$95L6I-\KXW\J8KF3LND;O9
MO*_9^(-AQ68T[ZMF$[E<KS&TO*;/BK['DDSPB5HS;!D/O1O8CM1LS)&*36.[
M&*`K;I"3:C2`?Y9[R3UUSI/`?D=4-'V$<XY><YK#ET%-;;R\<6&P[QDDZUV5
MM,QC7@U5\_3P[)*W2G%:9K1CB)EVME@4V+4LJ4[UX\0-6MUU2!/\XLFY-\\P
M?E/-<H^05DNEY\K^C\6)"G2.C2!,C#CQ9.9VV<?4\[4S=J5"N/9>O5MFW>QE
ME43-9F#]FV(@^(S1*TZ0I=?A/Y2!B>`6W[[LFXP_&W0M"NLK8/&[!:[F/+*Q
MO%%&AMPU6Q7-S3N+$Y:53H)!84[/QL@7%_D/1V($Q/QZAB@=(.I9)*?$'</K
M`,Z`7_E76./UVXX;33N5<E2(7CG:\]L-=V"8T>RQ%,ID52IIF:.DI*:MT\\C
MHJL%8BX(J@_4<(BT=%35(<JA2B%4SIN!<O%WD[3`.&F3X74M0IF^8SE\4\A.
M/6_4&?@+%"ZOASB7DI*@2,F]K3MY`K6^O13L(J1=1RJT9*'9D?-SIBY5:-;9
MMVE[@`.6<?N.+;RSZSRKVG9,77YR7C'83-.//&-/1J4KJ&3\9:L@^6EKR>B&
MF/O"?N&EROSW<E*-61HV'B@"-;KK@5VZ73;C']L@[%]9!G0$#A2YD&@7DU>&
MC_NF:(I0Z4$.:!&^_0`"RAG/WN5F(V`L/V^L?1?G=D!_SSXW_K^G\@)_K#/Q
M?.$*S^]Q^#!6R.Z7]Y4OW+?84U0'D@E*H?NL2#^XW"2:^P#-^U]R((^J6.Z]
M'SB"IVZNH(SMD?XCWE;R0O(93Q\$J+:*G7.'_NO)<>V%>-7DY?O:"YH:SNF\
M<[K8SP_ZR2CA.R,[[>^45.W3YOB`O:0RX#N-)RQQK)^*!=:9YE:S8V6]/\H:
MWL^,K5J32NOV"UFG",V^RX*F+P9$&1%(A-C[QE0!/UCT^:.L`U7()CX['N=8
MZCRB/P])E*1&2^!#MDAC["B"W0K;8[,N2KW)RV@U6)J<"/\`3B#&14B_0`E,
MW[!TU!/:DGPV]RB#1!XU>[]?UX<R^TE,P]?W.=)Y^_/V*$.81&<!#Y'W8$?_
M`%RD]SY_8/5TU`#K@Q\5*MAP=Q>U.!069CGE;'C46SR&!HR9\G5=F3IG[.MI
M%RFK(9T61[C$!$D5C".>YFW93]>JN721J,#44^)80=M"ACQZ^VQQK/"WK[34
MSDT)_A\"K6,,G^[!B#"Q#'OLH9;[>,[_`-3#%_+^(/L>]U-0%Z""B!1(8*S]
MI_MD%2C@K_T,8<:+]B!#H_2OI`L>\`-3^W_;^/[/^9_#]/H_I]NI_,"1<<V?
MBJ:0FW?X3S\"#5MQ7WKGD7^PS[`7L&6GJ-9?YI=@^Q7#A@UIX,PD/4E+^B/(
ME\G^4"BKUI\^LC^9^XPP\5S*JV-O@"G!`]-+G>EC;S9=)8-(08Y,NPJBFN_<
MSJN.G+8V<A$C!_7P=G&,3:_`!UZ4OCAT?+K(&Q1+AOW)G(MQRK[N+G=F+DGL
MFJ7W%^U`A2_O$<\`@_4C9]Z0KOU(8WO'=OIWO_\`NW60+9Q^9^-)I5=P_P`+
MQ^$QJ.X:.G7([]D'N(O:H6+583GR2[']E+KQ#6$"++)]T9CT-2(?*[%`@K=:
M?/K(-?B['Q?,\6T)M@!^#1^/8V"MJZJ;+)##'V2_<ZKZ(5IH:`ZK3EQ5`F`D
M!8!$DD3^Z0_QRM@#^D'4<]0/YU`+JW3XG?1XT&@\?/H'^(.2/$?'4SKZ1_BI
M^[Y@9?Z:*9OA_O\`??HO_DE2_P!X?J_R/6'R/<ZNH!7R+9^.5QKN8K\L#\-B
M[JS1CU<B+OK[&FNH':'L)4X@*,VOSA&SOV(6T2_$(T*HD64[&2`''8>BGH#0
M[&Q\7ZFWSCW?U.#8<B4Z4=M:":[(88EK(T!6L2QA-9(^WN26=6M!2@?^E9VD
M*!(GY`%,#?W>JN4:3`);J+'Q]+:HU=;,IQ(#:&V&6Q)`NCR&2(:&;C8XA+`6
MZBLSL;E.==XH6NEEOJ!U2'A$FGS!4$J8KCU-8ZP`\E)B(WP!(.7!IW[5$*'H
M/5/OK]D?K(BG_*`_7OVM^X._8>WTKYG?L/N=0"I;DR\6SO-L+3Y''X)ER)"%
M2<<;!V"0P=EGHUA"&BA*7%U;:Y0K[FL&KXL?6E"F.R49>QZBBE[?5U^(&KB"
MX=]]`:`'*_W+_:BOE#Z.:I?>_P"QP3$L-5])68_7`ROZ^+[Z>(!])^7[_L_U
M/<ZFH`7.,?'ZY6XH?7S\2BKLWK!SPB^;(9,U5.[30A"QQ>,G=RB=\06YHWVT
MJS[B9R_%'TB`(]74$TY8->'[S*5&W-T_'@F*K6"(()N3;O.V.<A:Q^2,"*#O
M3%F\`WLOZ+?#,F<KOMZ_;'^]TKRGY9D`ON3+QM.>*%+97Q3A>7A$=Q!HYR>Q
MO\6:<9@?E>O_`+;-19!ZX1S9.3&2*[^&I'*@N*_O>V/K%3JKE.D\@%ZA)\32
MQ''X,Q'CY]!3AIXO%G[%4SHT2,!]NJEM`X*,"86BL5]J>OYXU_NE\#U"M_2[
M]1SUW!]3<G%KZ%5/BC@GVR&XS)Z/[!\^^A?XDONNV#80JHIF^`.V_?`SOS"M
M/]>?5?G>X'O_`".IJ!(^(N4>,K(+[6:EFVG<2M=Y7-;+R`F:Y=2V+")ODNX;
MWS6]-O\`?8",-7'2MV4849[8I."6]D@JMF$<=!R("18H5R-0JT-CXL$=<L3G
M-3\#QW-YIC-2REITA@R^FDV!"Q/"-`?-8ARI9&.BFM_R/Y/0G(J2GN"(&<>H
M>CY=9`?_`(_&):BP2,,ZP9G2U=?>EHKQH7.W%1:\C#Z%-@=Q64`-]"7V-#8#
M/S'3;C]8-8@<%-_G?N=-?B""<3<EJ&2/]Z:+;=&;[R$N&I1USY-W8$*1!V5I
K<WN=4R'S^L35"I1C)9U#0>/PL$6&C7?K<KL3@^,JN9X98YSIX`</J`__V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
